Side-by-side comparison of AI visibility scores, market position, and capabilities
São Paulo B2B MVNO cutting corporate telecom costs 50%+ for 1,800+ companies with 322% NDR and 0.2% churn; YC W24 $13.2M Pioneer-backed targeting $5B Brazil B2B mobile market.
Salvy is a São Paulo, Brazil-based mobile virtual network operator (MVNO) for businesses — backed by Y Combinator (W24) with $13.2 million raised including a BRL 10 million seed round in May 2024 led by Pioneer Fund with Arash Ferdowsi (Dropbox co-founder), SaaSholic, StaminaVC, Zeno Ventures, and Latitud Ventures — providing B2B mobile phone plans that cut corporate telecom costs by 50%+ while delivering 322% Net Dollar Retention and 0.2% monthly churn by offering flexible corporate mobile management without the long-term carrier contracts and management overhead that traditional telecoms require. Founded in 2023 and serving 1,800+ companies managing 20,000+ mobile lines within its first year, Salvy operates in the $5 billion ARR Brazil B2B mobile market across 55+ million business mobile lines.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.